Role of inositol pyrophosphates in pancreatic beta cell function
Author: Rajasekaran, Subu Surendran
Date: 2018-06-15
Location: Rehabsalen, Norrbacka S2:01, Karolinska Universitetssjukhuset, Solna
Time: 09.00
Department: Inst för molekylär medicin och kirurgi / Dept of Molecular Medicine and Surgery
View/ Open:
Thesis (1.211Mb)
Abstract
Inositol pyrophosphates are high energy diphosphate containing molecules that are ubiquitous in eukaryotic cells. They have been implicated in diverse cellular processes ranging from DNA repair, telomere length regulation, ribosome synthesis, cell cycle regulation and apoptosis to osmoregulation, phosphate homeostasis, insulin sensitivity, vesicle trafficking, cytoskeletal rearrangement and exocytosis. The inositol pyrophosphate diphosphoinositol pentakisphosphate (IP7) is present in high levels in pancreatic β-cells. These cells secrete insulin to regulate blood glucose homeostasis. Previous work has shown that IP7 is important for maintaining the immediate exocytotic capacity of β-cells and thus the potential to secrete insulin. However, the physiological regulation and role of IP7 in these cells, especially in response to glucose, remained unexplored. The aims of this Ph.D. work were to investigate the dependence of IP7 on cellular bioenergetic status, the consequent action of IP7 in glucose-induced insulin secretion and IP7’s broader role in cellular regulation.
We initially discovered the dependence of IP7 on the cellular ATP/ADP levels in insulin secreting HIT-T15 cells. Off-target reduction in ATP/ADP, upon use of a selection of signal transduction inhibitors, decreased IP7 levels. The compounds tested included inhibitors of phosphatidylinositol 3-kinase, PI3K, (wortmannin, LY294002), phosphatidylinositol 4-kinase, PI4K, (Phenylarsine Oxide, PAO), phospholipase C, PLC, (U73122) and the insulin receptor (HNMPA). We demonstrated for the first time a direct positive correlation between intracellular changes in endogenous ATP/ADP and IP7, pinpointing the regulation of IP7 by the cellular bioenergetic status. This is in agreement with the enzymatic properties of the inositol hexakisphosphate kinases (IP6Ks) that synthesize IP7. Their high Km for ATP makes IP6Ks sensitive to ATP changes. We have also revealed that some inhibitors (PAO, U73122 and LY294002) directly inhibit IP6Ks.
We then investigated how physiological changes in ATP/ADP regulate IP7 production in β-cells. Glucose stimulation induced a transient increase in IP7 levels in insulin secreting cell lines and primary islets. Other secretagogues known to increase ATP/ADP, e.g. leucine, also increased IP7 levels. Silencing IP6K1, but not IP6K2, decreased glucose-mediated IP7 production and first phase insulin secretion. Therefore, IP6K1 acts as a key metabolic sensor. In diabetic ob/ob mouse islets the deranged ATP/ADP levels were mirrored by perturbed IP7 production and insulin secretion. Altogether these studies show that metabolic changes in the β-cells are reflected in IP7 levels, which consequently affect exocytosis under both physiological and pathophysiological conditions.
IP7 inhibition of Akt/PKB had been described in insulin-sensitive tissues, such as liver, muscle and white fat. β-cells are also regulated by insulin. Therefore, we examined the role of IP7 in modulating the activity of Akt/PKB. To our surprise, the increase in IP7 generated by IP6K1 in glucose-stimulated β-cells was associated with higher Akt/PKB phosphorylation on the T308 and S473 sites. This indicates that IP7 activates Akt/PKB. The results cannot be explained by a direct effect of IP7 on Akt/PKB, because of the inhibitory nature of this interaction. Instead, we propose that Akt/PKB is indirectly activated by IP7 through the IP7-induced increase of insulin secretion and the consequent potentiation of the insulin feedback signaling on β-cell insulin receptors.
In conclusion, the dependence of IP7 on cellular bioenergetics status suggests that IP6K1, i.e. the kinase that produces IP7 under glucose stimulation, is a new metabolic sensor in β-cells and is a likely hostage to the disrupted metabolism of type-2 diabetes. The work on Akt/PKB also exposes the complexity of inositol pyrophosphate signaling in different biological settings. Collectively our new findings have considerably broadened the understanding of IP7 regulation and function in β-cells and islets under both physiological and diabetic conditions.
We initially discovered the dependence of IP7 on the cellular ATP/ADP levels in insulin secreting HIT-T15 cells. Off-target reduction in ATP/ADP, upon use of a selection of signal transduction inhibitors, decreased IP7 levels. The compounds tested included inhibitors of phosphatidylinositol 3-kinase, PI3K, (wortmannin, LY294002), phosphatidylinositol 4-kinase, PI4K, (Phenylarsine Oxide, PAO), phospholipase C, PLC, (U73122) and the insulin receptor (HNMPA). We demonstrated for the first time a direct positive correlation between intracellular changes in endogenous ATP/ADP and IP7, pinpointing the regulation of IP7 by the cellular bioenergetic status. This is in agreement with the enzymatic properties of the inositol hexakisphosphate kinases (IP6Ks) that synthesize IP7. Their high Km for ATP makes IP6Ks sensitive to ATP changes. We have also revealed that some inhibitors (PAO, U73122 and LY294002) directly inhibit IP6Ks.
We then investigated how physiological changes in ATP/ADP regulate IP7 production in β-cells. Glucose stimulation induced a transient increase in IP7 levels in insulin secreting cell lines and primary islets. Other secretagogues known to increase ATP/ADP, e.g. leucine, also increased IP7 levels. Silencing IP6K1, but not IP6K2, decreased glucose-mediated IP7 production and first phase insulin secretion. Therefore, IP6K1 acts as a key metabolic sensor. In diabetic ob/ob mouse islets the deranged ATP/ADP levels were mirrored by perturbed IP7 production and insulin secretion. Altogether these studies show that metabolic changes in the β-cells are reflected in IP7 levels, which consequently affect exocytosis under both physiological and pathophysiological conditions.
IP7 inhibition of Akt/PKB had been described in insulin-sensitive tissues, such as liver, muscle and white fat. β-cells are also regulated by insulin. Therefore, we examined the role of IP7 in modulating the activity of Akt/PKB. To our surprise, the increase in IP7 generated by IP6K1 in glucose-stimulated β-cells was associated with higher Akt/PKB phosphorylation on the T308 and S473 sites. This indicates that IP7 activates Akt/PKB. The results cannot be explained by a direct effect of IP7 on Akt/PKB, because of the inhibitory nature of this interaction. Instead, we propose that Akt/PKB is indirectly activated by IP7 through the IP7-induced increase of insulin secretion and the consequent potentiation of the insulin feedback signaling on β-cell insulin receptors.
In conclusion, the dependence of IP7 on cellular bioenergetics status suggests that IP6K1, i.e. the kinase that produces IP7 under glucose stimulation, is a new metabolic sensor in β-cells and is a likely hostage to the disrupted metabolism of type-2 diabetes. The work on Akt/PKB also exposes the complexity of inositol pyrophosphate signaling in different biological settings. Collectively our new findings have considerably broadened the understanding of IP7 regulation and function in β-cells and islets under both physiological and diabetic conditions.
List of papers:
I. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity. Subu Surendran Rajasekaran, Christopher Illies, Stephen B. Shears, Huanchen Wang, Thais S. Ayala, Joilson O. Martins, Elisabetta Daré, Per-Olof Berggren, Christopher J. Barker. Cellular Signalling. 2018 Jan;42:127-133.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cells. Subu Surendran Rajasekaran, Jaeyoon Kim, Gian-Carlo Gaboardi, Jesper Gromada, Stephen B. Shears, Karen Tiago dos Santos, Eduardo Lima Nolasco, Sabrina de Souza Ferreira, Christopher Illies, Martin Köhler, Chunfang Gu, Sung Ho Ryu, Joilson O. Martins, Elisabetta Daré, Christopher J. Barker, Per-Olof Berggren. Cellular Signalling. 2018 Jun;46:120-128.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Inositol pyrophosphates and Akt: is the pancreatic β-cell the exception to the rule? Jaeyoon Kim, Subu Surendran Rajasekaran, Elisabetta Daré, Per-Olof Berggren, Christopher J. Barker. [Manuscript]
I. Protein kinase- and lipase inhibitors of inositide metabolism deplete IP7 indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity. Subu Surendran Rajasekaran, Christopher Illies, Stephen B. Shears, Huanchen Wang, Thais S. Ayala, Joilson O. Martins, Elisabetta Daré, Per-Olof Berggren, Christopher J. Barker. Cellular Signalling. 2018 Jan;42:127-133.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cells. Subu Surendran Rajasekaran, Jaeyoon Kim, Gian-Carlo Gaboardi, Jesper Gromada, Stephen B. Shears, Karen Tiago dos Santos, Eduardo Lima Nolasco, Sabrina de Souza Ferreira, Christopher Illies, Martin Köhler, Chunfang Gu, Sung Ho Ryu, Joilson O. Martins, Elisabetta Daré, Christopher J. Barker, Per-Olof Berggren. Cellular Signalling. 2018 Jun;46:120-128.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Inositol pyrophosphates and Akt: is the pancreatic β-cell the exception to the rule? Jaeyoon Kim, Subu Surendran Rajasekaran, Elisabetta Daré, Per-Olof Berggren, Christopher J. Barker. [Manuscript]
Institution: Karolinska Institutet
Supervisor: Barker, Christopher
Co-supervisor: Darè, Elisabetta; Berggren, Per-Olof
Issue date: 2018-05-25
Rights:
Publication year: 2018
ISBN: 978-91-7831-115-6
Statistics
Total Visits
Views | |
---|---|
Role ... | 375 |
Role ...(legacy) | 363 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Role ... | 2 | 3 | 0 | 1 | 2 | 3 | 2 |
File Visits
Views | |
---|---|
Thesis_Subu_Surendran_Rajasekaran.pdf | 244 |
Thesis_Subu_Surendran_Rajasekaran.pdf(legacy) | 155 |
null(legacy) | 2 |
Top country views
Views | |
---|---|
Sweden | 241 |
United States | 143 |
Germany | 63 |
China | 34 |
United Kingdom | 23 |
India | 17 |
Netherlands | 12 |
Finland | 10 |
Japan | 10 |
Singapore | 10 |
Top cities views
Views | |
---|---|
Solna | 70 |
Ashburn | 44 |
Stockholm | 23 |
Woodbridge | 12 |
Beijing | 8 |
Singapore | 8 |
Uppsala | 8 |
Dublin | 6 |
Göteborg | 6 |
London | 5 |